Prudent Man Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Buy |
14,654
+3,727
| +34% | +$400K | 0.5% | 43 |
|
|
2025
Q1 | $1.1M | Buy |
10,927
+531
| +5% | +$53.6K | 0.4% | 53 |
|
|
2024
Q4 | $929K | Sell |
10,396
-567
| -5% | -$50.6K | 0.34% | 68 |
|
|
2024
Q3 | $919K | Sell |
10,963
-3,328
| -23% | -$279K | 0.31% | 78 |
|
|
2024
Q2 | $1.1M | Buy |
14,291
+541
| +4% | +$41.7K | 0.39% | 57 |
|
|
2024
Q1 | $942K | Sell |
13,750
-626
| -4% | -$42.9K | 0.35% | 66 |
|
|
2023
Q4 | $831K | Sell |
14,376
-183
| -1% | -$10.6K | 0.31% | 72 |
|
|
2023
Q3 | $769K | Sell |
14,559
-587
| -4% | -$31K | 0.31% | 73 |
|
|
2023
Q2 | $819K | Sell |
15,146
-239
| -2% | -$12.9K | 0.31% | 69 |
|
|
2023
Q1 | $770K | Sell |
15,385
-34
| -0.2% | -$1.7K | 0.3% | 72 |
|
|
2022
Q4 | $713K | Buy |
15,419
+4,492
| +41% | +$208K | 0.29% | 74 |
|
|
2022
Q3 | $423K | Buy |
10,927
+15
| +0.1% | +$581 | 0.2% | 103 |
|
|
2022
Q2 | $407K | Sell |
10,912
-102
| -0.9% | -$3.8K | 0.19% | 106 |
|
|
2022
Q1 | $488K | Sell |
11,014
-661
| -6% | -$29.3K | 0.2% | 95 |
|
|
2021
Q4 | $496K | Buy |
11,675
+57
| +0.5% | +$2.42K | 0.19% | 101 |
|
|
2021
Q3 | $504K | Sell |
11,618
-106
| -0.9% | -$4.6K | 0.19% | 100 |
|
|
2021
Q2 | $501K | Buy |
11,724
+532
| +5% | +$22.7K | 0.19% | 97 |
|
|
2021
Q1 | $433K | Buy |
11,192
+422
| +4% | +$16.3K | 0.18% | 100 |
|
|
2020
Q4 | $387K | Sell |
10,770
-22
| -0.2% | -$791 | 0.16% | 108 |
|
|
2020
Q3 | $412K | Buy |
10,792
+387
| +4% | +$14.8K | 0.22% | 90 |
|
|
2020
Q2 | $365K | Buy |
+10,405
| New | +$365K | 0.32% | 84 |
|